Adjuvant chemo-immunotherapy may benefit patients with resected stage IB–IIIA NSCLC, trial suggests
Interim results from the NADIM ADJUVANT Phase III trial, led by the Spanish Lung Cancer Group (GECP), suggest…
Targeting metabolic reprogramming to overcome immune suppression in head and neck cancer
Head and neck cancer remains a major global health challenge, ranking among the six most common cancers worldwide…
New technology embeds unique genetic identifiers in engineered cells
Genetically engineered cell lines used in biomedical research have long been prone to misidentification and unauthorized use, wasting…
First FDA-approved islet transplant at UI Health ends insulin dependence
Doctors at UI Health performed the first islet transplant with Lantidra, the only therapy approved by the U.S.…
Mucus-inspired hydrogel improves healing in animal models of gastric injury
Hydrogels-materials like gelatin that can absorb and hold water-can aid wound healing and enable slow-release drug delivery, but…
New 3D eye model reveals causes of steroid-related glaucoma
The eye, like most organs, has an intricate plumbing system. Pressure builds when drainage is impaired, and this…